Press Release|Articles|June 3, 2025
Camber Pharmaceuticals Announces Addition of Olmesartan Medoxomil Tablets, USP
Listen
0:00 / 0:00
Key Takeaways
- Camber Pharmaceuticals introduces Olmesartan Medoxomil Tablets, USP, for hypertension treatment in adults and children aged six and older.
- The tablets are available in 5 mg, 20 mg, and 40 mg strengths, packaged in bottles of 30 and 90 tablets.
Advertisement
Camber Pharmaceuticals is excited to announce the addition of Olmesartan Medoxomil Tablets, USP, to its current portfolio.
Olmesartan Medoxomil Tablets, USP are indicated for the treatment of hypertension in adults and children six years of age and older to lower blood pressure.
Olmesartan Medoxomil Tablets, USP, are available in 5 mg, 20 mg, and 40 mg strengths, packaged in bottles of 30 and 90 tablets.
To find out more information on Olmesartan Medoxomil Tablets, USP, please visit:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
2
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
3
Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars
4
FDA Approves Depemokimab as Add-On Maintenance Treatment in Severe Asthma
5